4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001193125-26-386464
Chief Financial Officer sold 17,717 shares at $18.94 ($335,560)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Catinazzo Thomas · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-08 | Sale : show line 1 in the form 10b5-1 | −17,717 | $18.94 | $335,560 | 122,851 | D |
| Open-market sales · 17,717 sh · avg $18.94 · $335,560 | ||||||
Loading xslF345X06/ownership.xml…